The strategic alliance will drive innovation and expand clinical genetics, ensuring the continuity of current services while offering more comprehensive and advanced solutions.

Veritas Genetics, a LetsGetChecked company, announces the acquisition of NIMGenetics, a milestone transaction that represents a decisive step towards developing innovative solutions that will transform genetic diagnosis and prevention.

This acquisition combines NIMGenetics’ robust expertise in clinical diagnostics with Veritas Genetics’ international research and advanced technological capabilities, supported by the LetsGetChecked (LGC) group and healthcare investor Apposite Capital.

The integration of NIMGenetics, known for its extensive experience in clinical diagnostics and the design of advanced genetic panels, strengthens Veritas Genetics’ ability to tackle complex challenges in key areas such as oncology, rare diseases, and perinatal and reproductive medicine. This will be achieved by leveraging Veritas’ global infrastructure and LGC group’s innovative vision.

Javier de Echevarría, CEO of Veritas Genetics commented: “This acquisition represents a unique opportunity to combine strengths, expand our capacity for innovation, and continue leading the future of medical genetics with more comprehensive and personalized solutions for our clients. NIMGenetics brings undisputed prestige in the market and a highly talented and experienced team whose expertise will be crucial in reaching new milestones together within this industry.”

Anne-Laure Meynier, Partner at Apposite commented: “We are convinced that combining NIM with the Veritas and LGC operations will not only take NIM further with their innovations and market leadership but will also create a stronger operator to better serve patients in Spain and internationally.”

A Future of Innovation, Expansion, and Trust

Both companies are committed to ensuring the continuity of current services while working on a gradual integration that prioritizes operational excellence and regulatory compliance in all areas. This approach will allow Veritas Genetics and NIMGenetics to maintain the trust of their clients and partners, including those in both the public and private sectors.

Strengthening technological and operational infrastructure will drive the development of new projects and the expansion of services at both national and international levels. This synergy will also reinforce the position of both companies as strategic partners for hospitals, research centers, and healthcare professionals.

Commitment to Quality and Positive Impact

Veritas Genetics and NIMGenetics share a mission: transforming medicine through advanced genetics. The combination of talent, resources, and strategic vision opens a new chapter full of opportunities for both organizations, with a clear positive impact on patients and medical professionals, who will benefit from more accurate diagnostics and personalized genetic solutions.

About Veritas Genetics

Veritas Genetics, a company within the LetsGetChecked group, is a global leader in advanced genetic sequencing and full genome clinical interpretation, driving the transition toward personalized and preventive medicine. By using cutting-edge technologies and the highest security standards, Veritas helps individuals, healthcare professionals, and institutions worldwide understand and anticipate genetic risks, enabling more informed and proactive health decisions.

Focusing on innovation and accessibility, Veritas is transforming how we understand and care for health at every stage of life.

About NIMGenetics

NIMGenetics is a leading company in clinical genetic diagnostics, specialising in the design and marketing advanced genetic panels in areas such as oncology, neurology, and reproductive medicine. With a focus on innovation and quality, NIMGenetics has established itself as a benchmark in the medical sector.

About Apposite Capital LLP

Apposite Capital is a London-based independent investment firm specialising in investments in innovative healthcare companies. With a focus on growth and positive impact, Apposite Capital has supported organizations leading technological and clinical advancements, improving the quality and accessibility of healthcare worldwide.